Pharmafile Logo

Cuttsy+Cuttsy awarded Gold EcoVadis sustainability rating

December 11, 2024 | ESG, Sustainability 

Cuttsy+Cuttsy proudly announces their Gold Medal achievement from EcoVadis for 2024, placing them among the top 5% of companies assessed and within the 97th percentile, a testament to their unwavering commitment to sustainability and advanced ESG practices.

EcoVadis Gold Medal

Following the assessment of the 2024 EcoVadis submission, Cuttsy+Cuttsy is excited to announce they have been awarded a Gold Medal on their sustainability scorecard. This places the agency among the top 5% of companies assessed by EcoVadis in the past 12 months.

Not only this, but Cuttsy+Cuttsy’s high score placed them in the 97th percentile of all companies assessed in 2024, making them just shy of a platinum rating (the top possible rating within the EcoVadis scoring system).

EcoVadis, a globally trusted provider of business sustainability ratings with a network of over 130,000 rated companies, works with organisations of all sizes to measure sustainability performance. The platform offers detailed insights on environmental, social and governance (ESG) risk management, compliance and corporate sustainability goals.

Caroline Benson, Co-Founder, says, “We’re delighted with our ‘gold’ rating, a big advancement from last year’s ‘silver’, that showcases our dedication to continuous improvement across all our ESG practices.”

Mathew Cutts adds, “This achievement reinforces our pledge to uphold and exceed the highest standards in sustainability across our operations and value chain.”

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

Cuttsy+Cuttsy launches a practical roadmap to enhance clinical trial participant experience

Cuttsy+Cuttsy has launched The Experience Gap, a practical roadmap designed to help clinical trial teams improve participant engagement, support and retention across the full study journey.

Cuttsy+Cuttsy welcomes three new experts to the team

Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.

The gap between hype and reality, what patients really say about weight loss drugs

Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.

Why patient-centricity depends on site-centricity in clinical trials

Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.

From cloudy to clear: visualising complex data privacy information

Discover how clear communication principles can transform complex clinical research topics, as we conclude our Health Literacy series with a practical example on participant data transparency.

UK clinical trial regs are changing — here’s what’s happening

Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.

The invisible influence on trial retention: why caregivers must be part of the plan

Caregivers are vital to clinical trial retention, yet often overlooked—this article highlights their challenges, impact, and how to better support them.

Where it all began: why we wrote ‘The Site Factor’

Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for participants and researchers alike.

From text to context: Helping patients see side effects clearly

Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.

Why patient engagement must come first in rare disease trials

Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.